Kotiya D, Leibold N, Verma N, Jicha G, Goldstein L, Despa F. Rapid, scalable assay of amylin-β amyloid co-aggregation in brain tissue and blood. J Biol Chem. 2023;299:104682 pubmed publisher

Chow A, Uddin F, Liu M, Dobrin A, Nabet B, Mangarin L, et al. The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer. Immunity. 2023;56:93-106.e6 pubmed publisher

Patel A, Chen X, Huang X, Clay M, Komorova N, Krasin M, et al. The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma. Dev Cell. 2022;57:1226-1240.e8 pubmed publisher

Bitton A, Zheng Y, Houston J, Houston K. Investigating differences between tamoxifen resistant and sensitive breast cancer cells with flow cytometry. Cytometry A. 2021;99:164-169 pubmed publisher

Balakrishnan A, Rajan A, Salter A, Kosasih P, Wu Q, Voutsinas J, et al. Multispecific Targeting with Synthetic Ankyrin Repeat Motif Chimeric Antigen Receptors. Clin Cancer Res. 2019;25:7506-7516 pubmed publisher

Srivastava S, Salter A, Liggitt D, Yechan Gunja S, Sarvothama M, Cooper K, et al. Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting. Cancer Cell. 2019;35:489-503.e8 pubmed publisher